Site icon OncologyTube

Checkpoint Inhibitors in Hodgkin’s Lymphoma – Immune System Manipulation and CAR-T Cells

Joseph M. Connors, MD, FRCPC from The BC Cancer Agency Research Centre discusses checkpoint inhibitors in Hodgkin’s lymphoma and immune system manipulation and car-t cells at the 2017 American Society of Hematology.

Exit mobile version